Product Spotlight

Patient Resources

In The News

Xoft® is the only FDA cleared electronic brachytherapy (eBx®) system that has been used to treat 3,000 plus non-melanoma skin
cancer patients & is supported by positive
3-year clinical data.

iCAD is committed to providing advanced cancer detection and treatment options for unparalleled care.

Learn more about CAD technology and Xoft® eBx® for your cancer treatment.

  • SKIN eBx®

    Surgery is not the only option.

    Learn more about eBx® for non-melanoma skin cancer treatment.

  • IORT & APBI

    “I came in with cancer, went to sleep, and when I woke up, I was completely done with my breast cancer treatment.”

    –Marianne, IORT Patient  Learn more.

  • GYN eBx®

    Learn more about GYN eBx® for your gynecological cancer treatment.

  • Computer-Aided Detection (CAD)

    iCAD technology helps physicians and patients in the fight against the most prevalent cancers: breast, colorectal,  and prostate. Learn more about CAD.

03/20/15

iCAD to Present Positive Four-year Data on Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for Non-melanoma Skin Cancer (NMSC).
Read More

03/03/15

iCAD to Present at the 27th Annual Roth Conference on Wednesday March 11, 2015.
Read More

02/24/15

iCAD Reports Fourth Quarter and Fiscal Year 2014 Financial Results.
Read More

 

View All News & Events »

Connect with iCAD

© 2014, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and Never Stop Looking is a trademark of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.